biofilm-driven chronic respiratory disease
Clarametyx Biosciences Strengthens Leadership Team to Accelerate Pipeline and Corporate Development Progress
Clarametyx Biosciences; leadership team; executive promotions; pipeline development; corporate development; Steve St. Onge; Brendan Doran; immune-enabling therapies; biofilm-driven chronic respiratory disease